Mangalam Drugs and Organics Ltd MANGALAM-IN:National Stock Exchange of India

*Data is delayed | Exchange | INR
Last | 05/03/24 IST
101.30quote price arrow down-1.35 (-1.32%)
Volume
33,708
52 week range
90.80 - 132.45
Loading...
  • Open102.50
  • Day High103.55
  • Day Low100.60
  • Prev Close102.65
  • 52 Week High132.45
  • 52 Week High Date02/20/24
  • 52 Week Low90.80
  • 52 Week Low Date03/28/24

Key Stats

  • Market Cap19.13M
  • Shares Out15.83M
  • 10 Day Average Volume31,985.3
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change2.27

KEY STATS

  • Open102.50
  • Day High103.55
  • Day Low100.60
  • Prev Close102.65
  • 52 Week High132.45
  • 52 Week High Date02/20/24
  • 52 Week Low90.80
  • 52 Week Low Date03/28/24
  • Market Cap19.13M
  • Shares Out15.83M
  • 10 Day Average Volume31,985.3
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change2.27

RATIOS/PROFITABILITY

  • EPS (TTM)-10.74
  • P/E (TTM)-9.43
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date12/21/2017
  • Div Amount0.50
  • Split Date-
  • Split Factor-

Latest On Mangalam Drugs and Organics Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Mangalam Drugs and Organics Limited is an India-based manufacturer of active pharmaceutical ingredients (APIs) and intermediates. Under the Company's Fight Malaria Program, it supplies anti-malaria APIs worldwide. Its products include API, intermediates and specialty chemicals. Its API products include acyclovir, amodiaquine, artemether, artesunate, atazanavir sulfate, bisoprolol fumarate, chloroquine phosphate, furosemide and dolutegravir sodium. The Company's intermediates...
Govardhan Dhoot
Executive Chairman of the Board, Managing Director
Ajay Samant
Chief Financial Officer
Address
3Rd Floor
Rupam Building 239, P. D'mello Road
Mumbai
400001
India